Biology of the Radiotheranostic Approach
Alberto Vargas, MD, offers an in-depth exploration of theranostics in oncology, focusing on prostate cancer.
Read MoreSelect Page
Alberto Vargas, MD, is a specialist in oncological and molecular imaging at the New York University Grossman School of Medicine. Dr. Vargas is a professor and vice chair of oncologic imaging and strategy within the Department of Radiology. Dr. Vargas earned his medical degree from Central University of Venezuela in Caracas. He completed a fellowship in oncologic imaging at Memorial Sloan Kettering Cancer Center in New York, where he also completed his residency.
Dr. Vargas’ clinical and research interests focus on the use of advanced-imaging modalities, including diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging (MRI) and novel positron emission tomography (PET) tracers for the non-invasive diagnosis, staging, treatment response assessment, and follow-up of patients with cancer. Dr. Vargas is especially interested in imaging patients with cancers involving the urinary system (e.g. prostate, bladder, and kidneys) and the female reproductive organs (e.g. uterus and ovaries).
Posted by Alberto Vargas, MD | Dec 2024
Alberto Vargas, MD, offers an in-depth exploration of theranostics in oncology, focusing on prostate cancer.
Read MorePosted by Alberto Vargas, MD | Dec 2024
Alberto Vargas, MD, examines the integration of AI into prostate MRI, focusing on its current state, challenges, and future implications. In this 19-minute presentation, Dr. Vargas shares that current AI in prostate MRI aims to match the diagnostic accuracy of expert radiologists rather than surpass it, addressing challenges such as subjective variability in radiologist reports and optimization of workflow efficiency.
Deep learning, a subset of AI, emerges as the most promising approach, but concerns linger about its interoperability and blind spots. Ethical considerations are critical, especially the risk of creating unequal access to AI-driven diagnostics. The presentation also stresses the importance of user-friendly software integration within existing imaging platforms.
Dr. Vargas emphasizes the necessity of demonstrating value through improved patient outcomes and experiences. He takes a forward-looking perspective on AI’s evolving role in prostate MRI, balancing optimism with realistic expectations.
Read More